2008-07-02 23:53:16 - www.companiesandmarkets.com adds new report - ViroPharma Incorporated - SWOT Analysis

www.companiesandmarkets.com/Summary-Company-Profile/ViroPharma-I ..
ViroPharma Incorporated Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

ViroPharma is a biopharmaceutical company focused on the development and commercialization of products that address serious infectious diseases.

The company currently markets Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride, in the US. It is headquartered in Exton, Pennsylvania and employs about 70 people. The company recorded revenues of $167.2 million during the fiscal year ended December 2006, an increase of 26.3% over 2005. The operating profit of the company was $98.8 million during fiscal year 2006, an increase of 12.1% over 2005. The net profit was $66.7 million in fiscal year 2006, a decrease of 41.4% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available